Companies

ADC Therapeutics SA (ADCT) SEC filings

CIK 0001771910 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in V8 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)81.4 M69.6 M209.9 M
Net income (USD)-157.1 M
Diluted EPS (USD/shares)-1.12-2.94-2.01

Latest filings

FiledFormDescriptionPeriod
2026-10-138-KFORM 8-K items 1.01,2.02,3.02,9.012026-10-07
2026-08-14SCHEDULE 13GSCHEDULE 13G
2026-08-13S-8FORM S-8
2026-08-1310-Q10-Q2026-06-30
2026-08-138-KFORM 8-K items 2.02,7.01,9.012026-08-13
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-024FORM 42026-06-30
2026-07-024FORM 42026-06-30
2026-07-024FORM 42026-06-30
2026-07-024FORM 42026-06-30
2026-07-028-KFORM 8-K items 5.022026-06-30
2026-06-248-KFORM 8-K items 7.01,8.01,9.012026-06-24
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-034FORM 42026-06-01
2026-06-038-KFORM 8-K items 7.01,8.01,9.012026-06-03
2026-06-028-KFORM 8-K items 5.07,9.012026-06-01
2026-05-0410-Q10-Q2026-03-31
2026-05-048-K8-K items 2.02,9.012026-05-04
2026-04-24SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-20DEFA14AFORM DEFA14A

Forms on file (last 1,000): 6-K 126, 4 70, 8-K 36, 3 17, CORRESP 17, EFFECT 13, SC 13G/A 13, SCHEDULE 13G/A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ADCT (0.002 USD), /gw/filings/filings?ticker=ADCT&form=8-K, /gw/filings/facts?ticker=ADCT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange